TENAX THERAPEUTICS, INC. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/37202dcd-f72a-4b08-b7e7-a318237e6b8d/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $0 | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-099393 |
| FY 2024 | $0 | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-044398 |
| FY 2016 | $0 | 2016-01-01 – 2016-12-31 | evidence 0001654954-17-002098 |
| FY 2014 | $49.3k | 2014-05-01 – 2015-04-30 | evidence 0001354488-15-003333 |
| FY 2013 | $158.9k | 2013-05-01 – 2014-04-30 | evidence 0001354488-14-003782 |
| FY 2012 | $1.2M | 2012-05-01 – 2013-04-30 | evidence 0001354488-13-003629 |
| FY 2011 | $475.3k | 1967-05-26 – 2012-04-30 | evidence 0001354488-12-003634 |
| FY 2010 | $103.2k | 2010-05-01 – 2011-04-30 | evidence 0001354488-12-003634 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
TENAX THERAPEUTICS, INC. — all facts · Net Income · Operating Income